×
  • Category
  • Type
  • Advanced

Facteurs à prendre en considération pour l'optimisation du portefeuille national de vaccins contre la COVID-19

Country experiences with COVID-19 vaccination: Quick Reference Guide

Iraq_Update on Routine and COVID-19 Immunization

Yemen_Maximizing Covid-19 to Strengthen Routine Immunization

Syria_Bringing the service closer to communities

Nigeria_Thrive360

Sierra Leone_Thrive360

Cote d'Ivoire_Using rumor management system data to develop adaptive COVID-19 vaccination strategies

Bangladesh_Community Radio in Bangladesh

India_COVID-19 vaccine rollout and digital tools

South Sudan_Collecting and using COVID-19 data in resource constrained settings

India_Assam_Mobile Vans and Community Engagement to increase uptake in hard to reach

DRC_High Volume Vaccination Site Experience

Afghanistan_Vaccination in humanitarian settings

W8.3 Application of technological advances to clinical trials

W8.2 Systems Vaccinology

W8.1 How can recent technological advances in systems vaccinology accelerate next-generation vaccine development?

W7.3 How can innovation in regulatory science inform the regulatory process to facilitate the development of new vaccines?

W7.2 Enhancement in Laboratory Research to Support Innovations in Regulatory Science for the Evaluation of New Vaccines

W7.1 Contributions of Regulatory Science to Vaccine Access